In this Section |
259712 Tobacco use among pregnant women in Hungary: The unique role of an unplanned pregnancyTuesday, October 30, 2012
Background: Smoking during pregnancy is a risk factor for low birth weight (LBW) and preterm birth (PTB). High percentages of LBW (8.6%) and PTB (8.7%) in Hungary suggest a significant contribution of smoking to these outcomes. The goal of this research was to determine whether planned versus unplanned pregnancy contributed to smoking or cessation during pregnancy. . Methods: In a 2009-10 retrospective cohort study about smoking and cessation among 8,350 women, 42% smoked prior to pregnancy. Logistic regression was used to estimate whether a planned versus unplanned correlated to continued smoking during the pregnancy, controlling for other known risk factors. Results: 63.8% of pregnant women continued smoking after learning they were pregnant. If the pregnancy was unexpected, only 1 in 5 quit smoking. In logistic regression analysis, an expected pregnancy reduced the likelihood of continued smoking by 43 percent (OR=0.57, 95%CI=0.43-0.76), controlling for women's education, marital status, ethnicity, prior quit attempts, knowledge about the harms of tobacco, and exposure to secondhand smoke, having a smoking partner. Conclusion: Planned pregnancy have important implications for quitting. Identifying women whose pregnancy was not planned may indicate the need for tailored interventions that address the desirability of the pregnancy.
Learning Areas:
Administer health education strategies, interventions and programsPublic health or related research Learning Objectives: Keywords: Pregnancy, Smoking
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: As a master teacher of the Department of Family Care Methodology and Public Health at
University of Debrecen I am a researcher and coordinator of the specific program about tobacco smoking and pregnancy outcomes."Increasing capacity for tobacco research in Hungary" supported by the Fogarty International Center, the National Cancer Institute, and the National Institute of Drug Abuse (1 R01 TW007927-01). I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4163.0: Tobacco Control from Around the World
|